Adipose tissue-derived mesenchymal stem cells differentiated into hepatocyte-like cells in vivo and in vitro

Molecular Medicine Reports

Volumn 11, Issue 3, 2015, Pages 1722-1732

  Yin, Libo ^a   Zhu, Yuhua ^a   Yang, Jiangang ^a   Ni, Yijiang ^a   Zhou, Zhao ^a   Chen, Yu ^a   Wen, Lixing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adipose tissue; Cell; Differentiation; Liver injury; Mesenchymal stem cells

Indexed keywords

5' NUCLEOTIDASE; ADAPALENE; ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA1 INTEGRIN; BILIRUBIN GLUCURONIDE; CARBON TETRACHLORIDE; CD11B ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; GLYCOGEN; HLA DR ANTIGEN; LOW DENSITY LIPOPROTEIN; PROGRAMMED DEATH 1 LIGAND 1; THY 1 ANTIGEN; TRICHOSTATIN A; VIMENTIN; BIOLOGICAL MARKER;

ADIPOSE DERIVED STEM CELL; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOLOGICAL ACTIVITY; CELL AGGREGATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL ORGANELLE; CELL PROLIFERATION; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; FIBROBLAST; FLOW CYTOMETRY; GOLGI COMPLEX; HEPATOCYTE LIKE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER INJURY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MITOCHONDRION; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; RAT; ROUGH ENDOPLASMIC RETICULUM; STEM CELL CULTURE; T LYMPHOCYTE; TRANSMISSION ELECTRON MICROSCOPY; ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; CELL CYCLE; CYTOLOGY; DRUG-INDUCED LIVER INJURY; LIVER FUNCTION TEST; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHENOTYPE;

BOVINAE; MUS; MUS MUSCULUS;

ADIPOSE TISSUE; ANIMALS; BIOMARKERS; CELL CYCLE; CELL DIFFERENTIATION; DRUG-INDUCED LIVER INJURY; HEPATOCYTES; HUMANS; LIVER FUNCTION TESTS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MODELS, ANIMAL; PHENOTYPE;

EID: 84916605236     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2935     Document Type: Article

References (44)

1. van Poll D, Parekkadan B, Cho CH, et al: Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47: 1634-1643, 2008.
2. Kashofer K and Bonnet D : Gene therapy progress and prospects: stem cell plasticity. Gene Ther 12: 1229-1234, 2005.
3. Kern S, Eichler H, Stoeve J, Klüter H and Bieback K: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301, 2006.
4. Devine SM, Cobbs C, Jennings M, Bartholomew A and Hoffman R: Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101: 2999-3001, 2003.
5. Tepliashin AS, Chupikova NI, Korzhikova SV, et al: Comparative analysis of cell populations with a phenotype similar to that of mesenchymal stem cells derived from subcutaneous fat. Tsitologiia 47: 637-643, 2005 (in Russian).
6. Malhi H, Irani AN, Gagandeep S and Gupta S: Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepatocytes. J Cell Sci 115: 2679-2688, 2002.
7. Young HE, Steele TA, Bray RA, et al: Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264: 51-62, 2001.
8. Lowes KN, Croager EJ, Olynyk JK, Abraham LJ and Yeoh GC: Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J Gastroenterol Hepatol 18: 4-12, 2003.
9. Zuk PA, Zhu M, Ashjian P, et al: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295, 2002.
10. Lagasse E, Connors H, Al-Dhalimy M, et al: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6: 1229-1234, 2000.
11. Alison MR, Poulsom R, Jeffery R, et al: Hepatocytes from non-hepatic adult stem cells. Nature 406: 257, 2000.
12. Herzog EL, Chai L and Krause DS: Plasticity of marrow-derived stem cells. Blood 102: 3483-3493, 2003.
13. Vassilopoulos G, Wang PR and Russell DW: Transplanted bone marrow regenerates liver by cell fusion. Nature 422: 901-904, 2003.
14. Wang X, Willenbring H, Akkari Y, et al: Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422: 897-901, 2003.
15. Wagner W, Wein F, Seckinger A, et al: Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416, 2005.
16. Snykers S, Vanhaecke T, De Becker A, et al: Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow. BMC Dev Biol 7: 24, 2007.
17. Yamamoto H, Quinn G, Asari A, et al: Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application. Hepatology 37: 983-993, 2003.
18. Kim JW, Kim SY, Park SY, et al: Mesenchymal progenitor cells in the human umbilical cord. Ann Hematol 83: 733-738, 2004.
19. Reyes M, Lund T, Lenvik T, et al: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 2615-2625, 2001.
20. Teratani T, Yamamoto H, Aoyagi K, et al: Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 41: 836-846, 2005.
21. Yamamoto Y, Teratani T, Yamamoto H, et al: Recapitulation of in vivo gene expression during hepatic differentiation from murine embryonic stem cells. Hepatology 42: 558-567, 2005.
22. Baertschiger RM, Serre-Beinier V, Morel P, et al: Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver. PLoS One 4: e6657, 2009.
23. Chien CC, Yen BL, Lee FK, et al: In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells 24: 1759-1768, 2006.
24. Herold C, Ganslmayer M, Ocker M, et al: The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol 36: 233-240, 2002.
25. Vinken M, Henkens T, Vanhaecke T, et al: Trichostatin a enhances gap junctional intercellular communication in primary cultures of adult rat hepatocytes. Toxicol Sci 91: 484-492, 2006.
26. Henkens T, Papeleu P, Elaut G, et al: Trichostatin A, a critical factor in maintaining the functional differentiation of primary cultured rat hepatocytes. Toxicol Appl Pharmacol 218: 64-71, 2007.
27. Bochev I, Elmadjian G, Kyurkchiev D, et al: Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int 32: 384-393, 2008.
28. McIntosh K, Zvonic S, Garrett S, et al: The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 24: 1246-1253, 2006.
29. Battiwalla M and Hematti P: Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 11: 503-515, 2009.
30. Dinarello CA: The interleukin-1 family: 10 years of discovery. FASEB J 8: 1314-1325, 1994.
31. Ortiz LA, Dutreil M, Fattman C, et al: Interleukin 1 receptor antagonist mediates the anti-inflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104: 11002-11007, 2007.
32. Ponte AL, Marais E, Gallay N, et al: The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737-1745, 2007.
33. Potian JA, Aviv H, Ponzio NM, Harrison JS and Rameshwar P: Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171: 3426-3434, 2003.
34. Tang J, Wang J, Yang J, et al: Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 36: 644-650, 2009.
35. Greco SJ and Rameshwar P: Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies. Biologics 2: 699-705, 2008.
36. Mouiseddine M, Fraņois S, Semont A, et al: Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol 80 Spec No 1: S49-55, 2007.
37. Oyagi S, Hirose M, Kojima M, et al: Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 44: 742-748, 2006.
38. Pan MX, Hou WL, Zhang QJ, et al: Infusion of autologous mesenchymal stem cells prolongs the survival of dogs receiving living donor liver transplantation. J South Med Univ (in Chinese).
39. Kuo YR, Goto S, Shih HS, et al: Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation 87: 1769-1777, 2009.
40. Matsuda Y, Matsumoto K, Ichida T and Nakamura T: Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 118: 643-649, 1995.
41. Silva GV, Litovsky S, Assad JA, et al: Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111: 150-156, 2005.
42. Phinney DG and Prockop DJ: Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair ? current views. Stem Cells 25: 2896-2902, 2007.
43. Krampera M, Cosmi L, Angeli R, et al: Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24: 386-398, 2006.
44. Rasmusson I, Uhlin M, Le Blanc K and Levitsky V: Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. J Leukoc Biol 82: 887-893, 2007.